Alliancebernstein L.P. Reduces Stake in agilon health, inc. (NYSE:AGL)

Alliancebernstein L.P. reduced its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 20.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 381,390 shares of the company's stock after selling 95,550 shares during the period. Alliancebernstein L.P. owned approximately 0.09% of agilon health worth $725,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Oak Thistle LLC bought a new position in shares of agilon health in the 4th quarter valued at $25,000. Ieq Capital LLC bought a new position in agilon health in the 4th quarter valued at approximately $26,000. Signaturefd LLC raised its holdings in agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after buying an additional 8,467 shares during the last quarter. Raymond James Financial Inc. bought a new position in agilon health in the 4th quarter valued at approximately $33,000. Finally, Symphony Financial Services Inc. raised its holdings in agilon health by 44.3% during the 4th quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company's stock worth $44,000 after purchasing an additional 7,058 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Cowen restated a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Sanford C. Bernstein upgraded shares of agilon health from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Needham & Company LLC restated a "hold" rating on shares of agilon health in a report on Friday, March 21st. Robert W. Baird lowered their price target on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Finally, Citigroup upgraded shares of agilon health from a "sell" rating to a "neutral" rating and raised their price target for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $4.60.

agilon health Trading Down 1.0 %

NYSE:AGL traded down $0.04 during trading hours on Thursday, reaching $3.88. The company's stock had a trading volume of 709,512 shares, compared to its average volume of 4,803,386. The firm has a market capitalization of $1.60 billion, a price-to-earnings ratio of -4.12 and a beta of 0.38. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a 50-day simple moving average of $4.17 and a 200-day simple moving average of $3.13.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.